메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
김혜원 (연세대학교 세브란스병원 약무국) 손가영 (연세대학교 세브란스병원 약무국) 금민정 (연세대학교 세브란스병원 약무국) 김재송 (연세대학교 세브란스병원) 손은선 (세브란스병원)
저널정보
한국병원약사회 병원약사회지 병원약사회지 제34권 제3호
발행연도
2017.8
수록면
313 - 321 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor antagonist, which reduces ischemic adverse events, is the established standard of care in acute coronary syndrome (ACS) patients who have undergone percutaneous coronary intervention (PCI). Guidelines of the European Society of Cardiology, American College of Cardiology/American Heart Association, and the Korean society interventional cardiology, recommend the use of clopidogrel, prasugrel, or ticagrelor in combination with aspirin as DAPT. However, there are differences amongst the various guidelines, in detailed recommendations for P2Y12 receptor antagonists. This study aimed to compare the incidence of cardiovascular events according to the type of P2Y12 receptor antagonists in combination with aspirin, in post-PCI DAPT patients. This retrospective study was a follow up after 12 months of starting DAPT, in ACS patients who had undergone PCI at the Severance Hospital between January 1, 2014 to December 31, 2014. Patients were divided into 2 groups: clopidogrel group and ticagrelor group, according to the P2Y12 receptor antagonist combined with aspirin. The baseline characteristics of patients and incidence of cardiovascular events (mortality, myocardial infarction, stent thrombosis, stroke, and bleeding) were analyzed and compared between groups. A total of 715 patients were divided into the clopidogrel group (n=635) and the ticagrelor group (n=80). Total incidence of cardiovascular events was higher in the ticagrelor group than clopidogrel group(11.3% vs. 5.7%, respectively; p=0.081). There was no significant difference in the incidence of death, myocardial infarction, stent thrombosis and stroke, but the incidence of bleeding was significantly higher in the ticagrelor group than in the clopidogrel group(7.5% vs. 2.4%, respectively; p 0.05). This study revealed the differences in the incidence of cardiovascular events according to the type of P2Y12 receptor antagonists used in combination with aspirin as DAPT. As compared with clopidogrel, a higher rate of bleeding with ticagrelor suggests that ticagrelor should be used with caution due to an increased risk of bleeding.

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0